NASDAQ:TCRX | Insider Transactions — Page 2 | TScan Therapeutics, Inc.

TCRX Insider Transactions — Page 2

104 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–104; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
667, L.P.Director2021-07-20Purchase104,698.0$15.0
Baker Bros. Advisors (GP) LLCDirector2021-07-20Purchase104,698.0$15.0
Westphal Christoph HTenPercentOwner2021-07-20Purchase133,333.0$15.0
Silver Brian M.Chief Financial Officer2021-07-20Purchase1,000.0$15.0